Figure 1.
Candidate biomarkers in the mechanism of action and metabolism of the drugs in the Nab-paclitaxel/gemcitabine (A) and FOLFIRINOX (B) regimens.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.